Fusion Pharmaceuticals Inc. Operating Cash Flow
Fusion Pharmaceuticals Inc. reported Operating Cash Flow of -$27.31 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$27.31M.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$17.94M.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$18.84M.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$19.58M.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$81.80M.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$73.28M.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$75.74M.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$29.77M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$27.31M 10-Q · filed 2024-05-07 | -$45.25M derived: sum of 2 quarters · filed 2024-05-07 | -$64.09M derived: sum of 3 quarters · filed 2024-05-07 | -$83.67M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | -$17.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$36.78M derived: sum of 2 quarters · filed 2024-03-20 | -$56.37M derived: sum of 3 quarters · filed 2024-03-20 | -$81.80M 10-K · filed 2024-03-20 |
| 2023-09-30 | -$18.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$38.42M derived: sum of 2 quarters · filed 2023-11-07 | -$63.86M 10-Q · filed 2023-11-07 | -$83.22M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | -$19.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$45.02M 10-Q · filed 2023-08-08 | -$64.38M derived: sum of 3 quarters · filed 2024-05-07 | -$86.01M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | -$25.43M 10-Q · filed 2024-05-07 | -$44.80M derived: sum of 2 quarters · filed 2024-05-07 | -$66.42M derived: sum of 3 quarters · filed 2024-05-07 | -$83.74M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$19.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$40.99M derived: sum of 2 quarters · filed 2024-03-20 | -$58.30M derived: sum of 3 quarters · filed 2024-03-20 | -$73.28M 10-K · filed 2024-03-20 |
| 2022-09-30 | -$21.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$38.94M derived: sum of 2 quarters · filed 2023-11-07 | -$53.91M 10-Q · filed 2023-11-07 | -$70.24M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$17.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$32.29M 10-Q · filed 2023-08-08 | -$48.61M derived: sum of 3 quarters · filed 2023-08-08 | -$70.12M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$14.97M 10-Q · filed 2023-05-11 | -$31.30M derived: sum of 2 quarters · filed 2023-05-11 | -$52.81M derived: sum of 3 quarters · filed 2023-05-11 | -$70.11M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$16.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$37.84M derived: sum of 2 quarters · filed 2023-03-16 | -$55.14M derived: sum of 3 quarters · filed 2023-03-16 | -$75.74M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$21.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$38.82M derived: sum of 2 quarters · filed 2022-11-08 | -$59.41M 10-Q · filed 2022-11-08 | -$62.49M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$17.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$37.90M 10-Q · filed 2022-08-09 | -$40.98M derived: sum of 3 quarters · filed 2022-08-09 | -$53.85M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$20.60M 10-Q · filed 2022-05-10 | -$23.68M derived: sum of 2 quarters · filed 2022-05-10 | -$36.55M derived: sum of 3 quarters · filed 2022-05-10 | -$42.74M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$15.95M derived: sum of 2 quarters · filed 2022-03-17 | -$22.15M derived: sum of 3 quarters · filed 2022-03-17 | -$29.77M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$12.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$19.07M derived: sum of 2 quarters · filed 2021-11-09 | -$26.68M 10-Q · filed 2021-11-09 | -$30.52M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$13.82M 10-Q · filed 2021-08-10 | -$17.65M derived: sum of 3 quarters · filed 2021-08-10 | -$20.68M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$7.62M 10-Q · filed 2021-05-11 | -$11.45M derived: sum of 2 quarters · filed 2021-05-11 | -$14.48M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | -$3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$6.86M derived: sum of 2 quarters · filed 2021-03-25 | -$13.69M 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$9.86M 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | -$6.83M 10-Q · filed 2020-08-11 |